Skip to content

Cross-sectional survey for BoPD diagnosis and disease management in Japan

Cross-sectional survey for BoPD diagnosis and disease management in Japan - Cross-sectional survey for BoPD in Japan

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045599
Enrollment
400
Registered
2021-09-29
Start date
2021-10-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline personality disorder

Interventions

None listed

Sponsors

Nippon Boehringer Ingelheim Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Physicians and psychologists who have been taking care of patients or clients (with or without notification) diagnosed with BoPD using DSM-5 or other BoPD diagnosis criteria for at least a month

Exclusion criteria

Exclusion criteria: Steering committee members and advisors for this study, and physicians and psychologists affiliated with NBI, Mebix and Qlife

Design outcomes

Primary

MeasureTime frame
(1)Background of study subjects (2)Number of BoPD patients (or clients), experiences and rate of outpatients (3)Background, diagnosis and treatment for BoPD patients or clients

Secondary

MeasureTime frame
(1) Feasibility of next future studies

Countries

Japan

Contacts

Public ContactTomoyoshi Kaneko

Mebix, Inc. Division of research promotion

BoPD_survey@mebix.co.jp03-4362-4500

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026